ArticleCancers2024

Intracranial Efficacy of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in Real-World Patients with Non-Small-Cell Lung Cancer and EGFR or ALK Alterations.

Marcus Rathbone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.